{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:41:35Z","timestamp":1776184895816,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,6,11]],"date-time":"2004-06-11T00:00:00Z","timestamp":1086912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/1471-244x-4-16","type":"journal-article","created":{"date-parts":[[2004,6,17]],"date-time":"2004-06-17T06:23:08Z","timestamp":1087453388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Three year naturalistic outcome study of panic disorder patients treated with paroxetine"],"prefix":"10.1186","volume":"4","author":[{"given":"Pinhas N","family":"Dannon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iulian","family":"Iancu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Lowengrub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Grunhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,6,11]]},"reference":[{"issue":"Suppl 10","key":"55_CR1","first-page":"3","volume":"57","author":"RM Hirschfeld","year":"1996","unstructured":"Hirschfeld RM: Panic Disorder: Diagnosis, epidemiology, and clinical course. J Clin Psychiatry. 1996, 57 (Suppl 10): 3-8.","journal-title":"J Clin Psychiatry"},{"key":"55_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0022-3956(93)90021-S","volume":"27","author":"C Salzman","year":"1993","unstructured":"Salzman C: Benzodiazepine treatment of panic and agarophobic sympthoms: use, dependence, toxicity, abuse. J Psychiatric research. 1993, 27: 97-100. 10.1016\/0022-3956(93)90021-S.","journal-title":"J Psychiatric research"},{"issue":"6","key":"55_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1176\/ajp.149.6.778","volume":"149","author":"AT Beck","year":"1992","unstructured":"Beck AT, Sokol L, Clark D, et al: A crossover study of focused cognitive therapy for panic disorder. Am J Psychiatry. 1992, 149 (6): 778-783.","journal-title":"Am J Psychiatry"},{"issue":"Suppl 2","key":"55_CR4","first-page":"26","volume":"58","author":"JR Davidson","year":"1997","unstructured":"Davidson JR: The use of benzodiazepines in panic disorder. J Clin Psychiatry. 1997, 58 (Suppl 2): 26-8.","journal-title":"J Clin Psychiatry"},{"key":"55_CR5","first-page":"17","volume":"59 Suppl 8","author":"JR Davidson","year":"1998","unstructured":"Davidson JR: The long-term treatment of panic disorder. J Clin Psychiatry. 1998, 59 Suppl 8: 17-21.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"55_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2165\/00003495-199855010-00007","volume":"55","author":"NS Gunasekara","year":"1998","unstructured":"Gunasekara NS, Noble S, Benfield P: Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Drugs. 1998, 55 (1): 85-120.","journal-title":"Drugs"},{"issue":"Suppl 2","key":"55_CR7","first-page":"20","volume":"58","author":"JW Jefferson","year":"1997","unstructured":"Jefferson JW: Antidepressants in panic disorder. J Clin Psychiatry. 1997, 58 (Suppl 2): 20-4.","journal-title":"J Clin Psychiatry"},{"key":"55_CR8","first-page":"18","volume":"Supple 365","author":"NK Rosenberg","year":"1991","unstructured":"Rosenberg NK, Andersch S, Kullingsjo H, et al: Efficacy and safety of Alprazolam, Impramine and placebo in treatment of panic disorder. Acta Psychiatrica Scandinavica. 1991, Supple 365: 18-27.","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"55_CR9","first-page":"251","volume":"12","author":"K Medign","year":"1992","unstructured":"Medign K, Westberg P, Eriksson E: Superiority of Clomipramine over imipramine in the treatment of panic disorder: A placebo-controlled trial. J Clin Psychopharmacol. 1992, 12: 251-261.","journal-title":"J Clin Psychopharmacol"},{"issue":"supple 2","key":"55_CR10","first-page":"S13","volume":"14","author":"AG Wada","year":"1999","unstructured":"Wada AG: Antidepressants in Panic Disorder. Int Clin Psychopharmacol. 1999, 14 (supple 2): S13-7.","journal-title":"Int Clin Psychopharmacol"},{"issue":"May suppl","key":"55_CR11","first-page":"1","volume":"155","author":"American Psychiatric Association","year":"1998","unstructured":"American Psychiatric Association: Practice Guideline for the Treatment of Patients with Panic Disorder. Am J Psychiatry. 1998, 155 (May suppl): 1-34.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"55_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1034\/j.1600-0447.2002.02255.x","volume":"106","author":"A Bakkar","year":"2002","unstructured":"Bakkar A, van Balkom AJ, Spinhoven P: SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand. 2002, 106 (3): 163-7. 10.1034\/j.1600-0447.2002.02255.x.","journal-title":"Acta Psychiatr Scand"},{"key":"55_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00004850-199503000-00006","volume":"10","author":"W Boyer","year":"1995","unstructured":"Boyer W: Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks; A meta-analasis. Int Clin Psychopharmacol. 1995, 10: 45-49.","journal-title":"Int Clin Psychopharmacol"},{"key":"55_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00004850-198701000-00002","volume":"2","author":"JA De Boer","year":"1987","unstructured":"De Boer JA, Westenberg HGM, Kamerbeek WD, et al: Effects of serotonin uptake inhibitors in anxiety disorders: A double blind comparison of clomipramine and fluvoxamine. Int Clin psychopharmacol. 1987, 2: 21-32.","journal-title":"Int Clin psychopharmacol"},{"issue":"2","key":"55_CR15","first-page":"175","volume":"34","author":"RB Lydiard","year":"1998","unstructured":"Lydiard RB, Steiner M, Burnham D, Gergel I: Efficacy Studies of Paroxetine in Panic Disorder. Psychopharmacology Bulletin. 1998, 34 (2): 175-182.","journal-title":"Psychopharmacology Bulletin"},{"key":"55_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0447.1997.tb00388.x","volume":"95","author":"Y Lecrubier","year":"1997","unstructured":"Lecrubier Y, Bakker A, Dunber G, et al: A comparison of paroxetine, clompiramine and placebo in the treatment of panic disorder. Acta Psychiatr Scand. 1997, 95: 145-52.","journal-title":"Acta Psychiatr Scand"},{"key":"55_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1192\/bjp.167.3.374","volume":"167","author":"S Oehrberg","year":"1995","unstructured":"Oehrberg S, Christiansen PE, Behnke K, et al: Paroxetine in the treatment of panic disorder a randomised, double blind, placebo controlled study. Br J Psychiatry. 1995, 167: 374-9.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"55_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0009-9236(97)90198-3","volume":"61","author":"JG Modell","year":"1997","unstructured":"Modell JG, Katholi CR, Modell JD, DePalma RL: Pharmacoepidemiology and Drug Utilization. Comparative sexual side effects of burpropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther. 1997, 61 (4): 476-487.","journal-title":"Clin Pharmacol Ther"},{"key":"55_CR19","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1176\/ajp.155.11.1570","volume":"155","author":"D Michelson","year":"1998","unstructured":"Michelson D, Lydiard RB, Pollack MH, et al: Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The fluoxetine panic disorder study group. Am J Psychiatry. 1998, 155: 1570-1577.","journal-title":"Am J Psychiatry"},{"key":"55_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/10401230109148949","volume":"13","author":"MR Mavissakalian","year":"2001","unstructured":"Mavissakalian MR, Perel JM: 2nd year maintenance and discontinuation of imipramine in PD with agoraphobia. Ann Clin Psychiatry. 2001, 13: 63-67. 10.1023\/A:1016699922670.","journal-title":"Ann Clin Psychiatry"},{"issue":"12","key":"55_CR21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4088\/JCP.v60n1205","volume":"60","author":"A Bakkar","year":"1999","unstructured":"Bakkar A, Van-Dyck R, Spinhoven P, Van-Balcom AJ: Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. J Clin Psychiatry. 1999, 60 (12): 831-8.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"55_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1176\/ajp.155.1.36","volume":"155","author":"GC Ballenger","year":"1998","unstructured":"Ballenger GC, Wheadon DE, Steiner M, et al: Double-blind, fixed-dose placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry. 1998, 155 (1): 36-42.","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"55_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0924-977X(96)83858-2","volume":"6","author":"R Judge","year":"1996","unstructured":"Judge R, Burnham D, Steiner M, et al: Paroxetine long-term safety and efficacy in panic disorder and prevention of relapse: a double-blind study. Eur Neuropsychopharmacol. 1996, 6 (Suppl 1): 26-","journal-title":"Eur Neuropsychopharmacol"},{"key":"55_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1192\/bjp.178.6.543","volume":"178","author":"JM Park","year":"2001","unstructured":"Park JM, Mataix-Cols D, Marks IM, et al: Two\u2013year Follow-up after a randomized controlled trial of self and clinician accompanied exposure for phobia\/panic disorders. Br J Psychiatry. 2001, 178: 543-548. 10.1192\/bjp.178.6.543.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"55_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4088\/JCP.v61n0406","volume":"61","author":"SH Kennedy","year":"2000","unstructured":"Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM: Antideperessant induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. Journal Clin Psychiatry. 2000, 61 (4): 276-281.","journal-title":"Journal Clin Psychiatry"},{"key":"55_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1600-0447.1997.tb00389.x","volume":"95","author":"Y Lecrubier","year":"1997","unstructured":"Lecrubier Y, Judge R: Collaborative paroxetine Panic Study Investigators. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Acta Psychiatr Scand. 1997, 95: 153-60.","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"55_CR27","first-page":"755","volume":"33","author":"J Zajecka","year":"1997","unstructured":"Zajecka J, Mitchell S, Fawcett J: Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush sexual inventory. Psychopharmacol Bull. 1997, 33 (4): 755-60.","journal-title":"Psychopharmacol Bull"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-4-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-4-16\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-4-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-4-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:06:45Z","timestamp":1726240005000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-4-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,11]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-4-16","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,11]]},"assertion":[{"value":"5 November 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"16"}}